These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 11789213)
1. [Inhibitory effect of panicoin on platelet activation and its mechanism]. Han G; Yao Q; Li H Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jul; 20(7):527-9. PubMed ID: 11789213 [TBL] [Abstract][Full Text] [Related]
2. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815 [TBL] [Abstract][Full Text] [Related]
4. [Effects of neferine on platelet aggregation in rabbits]. Yu J; Hu WS Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. Gasser JA; Betterridge DJ J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976 [TBL] [Abstract][Full Text] [Related]
6. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP. Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476 [TBL] [Abstract][Full Text] [Related]
7. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334 [TBL] [Abstract][Full Text] [Related]
10. In vitro effects of ethanol on rabbit platelet aggregation, secretion of granule contents, and cyclic AMP levels in the presence of prostacyclin. Rand ML; Gross PL; Jakowec DM; Packham MA; Mustard JF Thromb Haemost; 1989 Apr; 61(2):254-8. PubMed ID: 2546284 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo and in vivo studies of CME-1, a novel polysaccharide purified from the mycelia of Cordyceps sinensis that inhibits human platelet activation by activating adenylate cyclase/cyclic AMP. Lu WJ; Chang NC; Jayakumar T; Liao JC; Lin MJ; Wang SH; Chou DS; Thomas PA; Sheu JR Thromb Res; 2014 Dec; 134(6):1301-10. PubMed ID: 25294588 [TBL] [Abstract][Full Text] [Related]
12. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM Platelets; 2015; 26(8):783-7. PubMed ID: 25734355 [TBL] [Abstract][Full Text] [Related]
14. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis. Chen CX; Jin RM; Li YK; Zhong J; Yue L; Chen SC; Zhou JY Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):126-30. PubMed ID: 1317985 [TBL] [Abstract][Full Text] [Related]
16. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction. Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation. Del Zar MM; Martinuzzo M; Falcón C; Cardinali DP; Carreras LO; Vacas MI J Clin Endocrinol Metab; 1990 Jan; 70(1):246-51. PubMed ID: 2294133 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity. Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative. Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]